Published online Feb 26, 2020. doi: 10.12998/wjcc.v8.i4.736
Peer-review started: December 1, 2019
First decision: December 23, 2019
Revised: January 12, 2020
Accepted: January 15, 2020
Article in press: January 11, 2020
Published online: February 26, 2020
Processing time: 87 Days and 1.3 Hours
Surgical resection is the preferred method for patients with complex liver cancer. But the tumor is in a special position, the surgery is highly risky, postoperative complications can easily occur, and the prognosis is not ideal.
To explore the safety and feasibility of complicated liver cancer surgery and improve the survival rate of patients.
To investigate the effectiveness of surgical resection for complex liver cancer and its influencing factors.
Fifty-seven patients who had complicated liver cancer and underwent surgical resection at our hospital from August 2015 to August 2016 were enrolled in this study. All patients were followed for three years, and their postoperative complications, survival, and factors that impacted their survival were analyzed.
The total incidence of postoperative complications was 45.61%, and the incidence of pleural effusion was the highest at 28.07%. There were no correlations between the 2-year and 3-year survival rates and sex, age, and HbsAg of the patients (P > 0.05). In terms of pathological parameters, the 2-year survival rates and 3-year survival rates were significantly different according to the presence of a tumor capsule, degree of liver cirrhosis, satellite or foci lesions, hepatic vein thrombosis, portal vein tumor thrombus, and intraoperative blood loss (P < 0.05).
The effectiveness of surgical resection for complex hepatocellular carcinoma may be affected by factors such as the presence of a tumor capsule, cirrhosis degree, satellite or focal lesions, hepatic vein embolization, portal vein tumor thrombus, and intraoperative blood loss. Therefore, these factors should be controlled and prevented during surgery to help improve patient survival after surgery.
The influencing factors of complicated hepatocellular carcinoma surgery should be further explored to further improve patient survival after surgery.